Equillium (EQ)
Develops EQ504, an investigational AhR modulator for ulcerative colitis and other inflammatory diseases.
$1.80
After hours+0.05 (+2.86%)
At close$1.75(−9.33%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 65.60% | 41.60M shares | |
|---|---|---|---|
| 66 holders · as of Jun 30, 2026 | |||
| Insiders | 1.50% | 951.2K shares | |
| 3 holders · as of Jun 5, 2026 | |||
| Strategic holders | 16.33% | 10.35M shares | |
| 2 holders · as of May 15, 2026 | |||
| Other | 16.57% | 10.51M shares | |
| remainder | |||
63.41M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
66 holders · 41.60M shares · 20 new positions · 37 increased · 14 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 6.49M | 10.24% | +6.49Mnew | Aug 14, 2026 |
| Decheng Capital LLC | 4.45M | 7.01% | 0 | Aug 14, 2026 |
| Affinity Asset Advisors, LLC | 4.10M | 6.47% | +2.87M | Aug 13, 2026 |
| Adar1 Capital Management, LLC | 3.76M | 5.93% | +31.9K | Aug 14, 2026 |
| Abrdn PLC | 3.63M | 5.73% | +278.8K | Jul 31, 2026 |
| Woodline Partners LP | 3.50M | 5.52% | 0 | Aug 14, 2026 |
| Ra Capital Management, L.P. | 3.10M | 4.88% | 0 | Aug 14, 2026 |
| Stempoint Capital LP | 2.02M | 3.18% | +2.02Mnew | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Janus Henderson Group PLC | 9.99% | 6.08M | 13G | Feb 6, 2026 |
| Adage Capital Management, L.P. | 9.99% | 6.01M | 13G | Nov 13, 2025 |
| ADAR1 Capital Management, LLC | 9.90% | 6.60M | 13G | May 15, 2026 |
| RA Capital Management, L.P. | 9.90% | 6.48M | 13G | Mar 20, 2026 |
| Decheng Capital Management IV (Cayman), LLC | 6.70% | 4.27M | 13G | May 15, 2026 |
| Affinity Asset Advisors, LLC | 6.50% | 4.10M | 13G | Aug 13, 2026 |
| Woodline Partners LP | 5.90% | 3.51M | 13G | Nov 14, 2025 |
| Aberdeen Group plc | 5.30% | 3.35M | 13G | May 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 5, 2026 | Stephen Connellyofficer: President and CSO | Sale | 30,975 | $2.94 | 762,025 |
| Jun 4, 2026 | Stephen Connellyofficer: President and CSO | Sale | 200,000 | $3.16 | 793,000 |
| Jun 5, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 14,584 | $2.93 | 62,586 |
| May 27, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 9,821 | $2.70 | 62,586 |
| May 28, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale · 3 lots | 86,012 | $2.80 | 62,586 |
| May 28, 2026 | Penny Tomofficer: Principal Accounting Officer | Sale | 65,000 | $2.95 | 0 |
| Mar 13, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 120,312 | $2.50 | 62,586 |
| Mar 9, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 181,219 | $2.00 | 62,586 |
| Feb 19, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale · 2 lots | 185,937 | $1.76 | 91,444 |
| Jan 8, 2026 | Penny Tomofficer: Principal Accounting Officer | Sale | 6,533 | $1.29 | 0 |
House and Senate disclosures
Not reported.